Bernstein upgraded Novo Nordisk (NVO) to Outperform from Market Perform.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- ICER update on GLP-1s a ‘win’ for Eli Lilly, says BofA
- Hims Stock (HIMS) Rises as FDA Publishes “Green List,” Novo Nordisk Shares Slip
- Posse of U.S. Law Firms Saddles Up for Court Showdown with Novo Nordisk (NVO)
- HIMS Stock Climbs 7% after Eli Lilly’s Knockoff Case Falls Flat
- Quantum Software Stocks Surge as Real-World Deals and Revenue Potential Drive Investors’ Attention